Albert David

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
685.00
0.5 (0.07%)
BSENSE

Feb 06

BSE+NSE Vol: 1.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -4.61% vs 6.12% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -93.27% vs 5.66% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.70% vs -26.04% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -77.19% vs 108.49% in Mar 2024

Compare Profit and Loss Results of Albert David
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
345.00
150.00
195.00
130.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
345.00
150.00
195.00
130.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-14.00
-5.00
-9.00
-180.00%
Raw Materials Consumed
130.00
113.00
17.00
15.04%
Power & Fuel Cost
14.00
2.00
12.00
600.00%
Employee Cost
109.00
6.00
103.00
1,716.67%
Operating Expenses
9.00
7.00
2.00
28.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
36.00
6.00
30.00
500.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
18.00
0.00
18.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
342.00
135.00
207.00
153.33%
Operating Profit (PBDIT) excl Other Income
3.00
15.00
-12.00
-80.00%
Other Income
29.00
2.00
27.00
1,350.00%
Operating Profit (PBDIT)
32.00
17.00
15.00
88.24%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
32.00
16.00
16.00
100.00%
Depreciation
6.00
3.00
3.00
100.00%
Profit Before Taxation & Exceptional Items
25.00
13.00
12.00
92.31%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
25.00
13.00
12.00
92.31%
Provision for Tax
8.00
3.00
5.00
166.67%
Profit After Tax
17.00
10.00
7.00
70.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
238.00
32.00
206.00
643.75%
Profit Available for appropriations
255.00
42.00
213.00
507.14%
Appropriations
255.00
42.00
213.00
507.14%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
30.14
1.22
28.92
2,370.49%
Profit And Loss - Net Sales
Net Sales 345.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.61% vs 6.12% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -93.27% vs 5.66% in Mar 2024

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.70% vs -26.04% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 17.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -77.19% vs 108.49% in Mar 2024